Granuloma Annulare Induced by Adalimumab / 대한피부과학회지
Korean Journal of Dermatology
;
: 656-659, 2011.
Article
in Korean
| WPRIM
| ID: wpr-171798
ABSTRACT
Adalimumab is the first fully humanized monoclonal anti-tumor necrosis factor alpha (TNF-alpha) antibody. This drug has been shown to be of benefit in patients with inflammatory diseases in which TNF-alpha is involved, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn's disease. As the use of adalimumab is becoming more widespread, cutaneous side effects are being increasingly reported. Various dermatologic adverse events have been reported in the literature, including injection site reactions, psoriasis-like eruption and pityriasis rosea. Herein, we describe a case of GA associated with adalimumab treatment for adult-onset Still's disease, which has not been reported in Korea.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Arthritis, Rheumatoid
/
Spondylitis, Ankylosing
/
Crohn Disease
/
Arthritis, Psoriatic
/
Tumor Necrosis Factor-alpha
/
Still's Disease, Adult-Onset
/
Granuloma Annulare
/
Pityriasis Rosea
/
Antibodies, Monoclonal, Humanized
/
Adalimumab
Limits:
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Korean Journal of Dermatology
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS